Home > Insider Trading > Filing (0000899243-20-010437)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc.	MYOK	Pharmaceutical Preparations (2834)	455500552

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1560168	C. Taylor Harris	C/O Myokardia, Inc. 1000 Sierra Point Parkway Brisbane CA 94005	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-04	3,750	$0.00	8,743	No	4	M	Direct
Common Stock	Disposition	2020-04-06	1,305	$46.99	7,438	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-04-04	3,750	$0.00	3,750	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500			No	4	M	Direct

Footnotes

Restricted Stock Units ("RSUs") convert into common stock on a one-for-one basis.
The disposition of the shares is solely to cover tax withholding obligations resulting from the vesting of RSUs reported herein.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from April 4, 2018, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.